hughes syndrome foundation
hughes syndrome foundation Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
the orchard white hart lane, basingstoke, hampshire, RG21 4AF
Website
http://aps-support.org.ukhughes syndrome foundation Estimated Valuation
Pomanda estimates the enterprise value of HUGHES SYNDROME FOUNDATION at £83k based on a Turnover of £172.3k and 0.48x industry multiple (adjusted for size and gross margin).
hughes syndrome foundation Estimated Valuation
Pomanda estimates the enterprise value of HUGHES SYNDROME FOUNDATION at £392.3k based on an EBITDA of £105.7k and a 3.71x industry multiple (adjusted for size and gross margin).
hughes syndrome foundation Estimated Valuation
Pomanda estimates the enterprise value of HUGHES SYNDROME FOUNDATION at £892.2k based on Net Assets of £379.8k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hughes Syndrome Foundation Overview
Hughes Syndrome Foundation is a live company located in hampshire, RG21 4AF with a Companies House number of 07268671. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2010, it's largest shareholder is unknown. Hughes Syndrome Foundation is a established, micro sized company, Pomanda has estimated its turnover at £172.3k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Hughes Syndrome Foundation Health Check
Pomanda's financial health check has awarded Hughes Syndrome Foundation a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 2 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
2 Weak
Size
annual sales of £172.3k, make it smaller than the average company (£796.3k)
£172.3k - Hughes Syndrome Foundation
£796.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (6.5%)
11% - Hughes Syndrome Foundation
6.5% - Industry AVG
Production
with a gross margin of 36.5%, this company has a comparable cost of product (36.5%)
36.5% - Hughes Syndrome Foundation
36.5% - Industry AVG
Profitability
an operating margin of 61.4% make it more profitable than the average company (5.5%)
61.4% - Hughes Syndrome Foundation
5.5% - Industry AVG
Employees
with 2 employees, this is below the industry average (19)
2 - Hughes Syndrome Foundation
19 - Industry AVG
Pay Structure
on an average salary of £24.7k, the company has an equivalent pay structure (£26.9k)
£24.7k - Hughes Syndrome Foundation
£26.9k - Industry AVG
Efficiency
resulting in sales per employee of £86.2k, this is more efficient (£51.3k)
£86.2k - Hughes Syndrome Foundation
£51.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Hughes Syndrome Foundation
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Hughes Syndrome Foundation
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Hughes Syndrome Foundation
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 13682 weeks, this is more cash available to meet short term requirements (102 weeks)
13682 weeks - Hughes Syndrome Foundation
102 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.4%, this is a lower level of debt than the average (27.9%)
0.4% - Hughes Syndrome Foundation
27.9% - Industry AVG
HUGHES SYNDROME FOUNDATION financials
Hughes Syndrome Foundation's latest turnover from December 2023 is £172.3 thousand and the company has net assets of £379.8 thousand. According to their latest financial statements, Hughes Syndrome Foundation has 2 employees and maintains cash reserves of £372.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 172,332 | 91,541 | 128,035 | 127,590 | 110,212 | 68,008 | 74,903 | 102,008 | 78,460 | 70,637 | 66,013 | 69,586 | 63,406 | |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | 92,184 | 13,849 | 61,761 | 35,570 | 28,432 | -28,011 | 13,917 | 20,105 | 18,529 | 7,986 | -31,030 | -12,751 | 4,294 | |
| Tax | ||||||||||||||
| Profit After Tax | 92,184 | 13,849 | 61,761 | 35,570 | 28,432 | -28,011 | 13,917 | 20,105 | 18,529 | 7,986 | -31,030 | -12,751 | 4,294 | |
| Dividends Paid | ||||||||||||||
| Retained Profit | 92,184 | 13,849 | 61,761 | 35,570 | 28,432 | -28,011 | 13,917 | 20,105 | 18,529 | 7,986 | -31,030 | -12,751 | 4,294 | |
| Employee Costs | 49,304 | 46,927 | 49,535 | 53,827 | 52,999 | 50,012 | 42,991 | 42,083 | 42,175 | 41,575 | 43,854 | 42,139 | 22,666 | |
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||||||||
| Intangible Assets | ||||||||||||||
| Investments & Other | ||||||||||||||
| Debtors (Due After 1 year) | ||||||||||||||
| Total Fixed Assets | ||||||||||||||
| Stock & work in progress | ||||||||||||||
| Trade Debtors | 852 | |||||||||||||
| Group Debtors | ||||||||||||||
| Misc Debtors | 8,381 | 6,750 | 60,000 | 5,252 | 250 | 1,315 | 1,698 | |||||||
| Cash | 372,844 | 282,171 | 256,869 | 154,331 | 173,238 | 145,232 | 177,088 | 163,156 | 142,961 | 124,182 | 115,131 | 147,416 | 159,009 | |
| misc current assets | 18,113 | 3,800 | ||||||||||||
| total current assets | 381,225 | 288,921 | 274,982 | 215,183 | 178,490 | 149,032 | 177,088 | 163,156 | 142,961 | 124,432 | 116,446 | 147,416 | 160,707 | |
| total assets | 381,225 | 288,921 | 274,982 | 215,183 | 178,490 | 149,032 | 177,088 | 163,156 | 142,961 | 124,432 | 116,446 | 147,416 | 160,707 | |
| Bank overdraft | ||||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | ||||||||||||||
| Group/Directors Accounts | ||||||||||||||
| other short term finances | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| other current liabilities | 1,417 | 1,297 | 1,207 | 3,169 | 2,046 | 1,020 | 1,065 | 1,050 | 960 | 960 | 960 | 900 | 1,440 | |
| total current liabilities | 1,417 | 1,297 | 1,207 | 3,169 | 2,046 | 1,020 | 1,065 | 1,050 | 960 | 960 | 960 | 900 | 1,440 | |
| loans | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | ||||||||||||||
| provisions | ||||||||||||||
| total long term liabilities | ||||||||||||||
| total liabilities | 1,417 | 1,297 | 1,207 | 3,169 | 2,046 | 1,020 | 1,065 | 1,050 | 960 | 960 | 960 | 900 | 1,440 | |
| net assets | 379,808 | 287,624 | 273,775 | 212,014 | 176,444 | 148,012 | 176,023 | 162,106 | 142,001 | 123,472 | 115,486 | 146,516 | 159,267 | |
| total shareholders funds | 379,808 | 287,624 | 273,775 | 212,014 | 176,444 | 148,012 | 176,023 | 162,106 | 142,001 | 123,472 | 115,486 | 146,516 | 159,267 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | ||||||||||||||
| Amortisation | ||||||||||||||
| Tax | ||||||||||||||
| Stock | ||||||||||||||
| Debtors | 1,631 | 6,750 | -60,852 | 55,600 | 5,252 | -250 | -1,065 | 1,315 | -1,698 | 1,698 | ||||
| Creditors | ||||||||||||||
| Accruals and Deferred Income | 120 | 90 | -1,962 | 1,123 | 1,026 | -45 | 15 | 90 | 60 | -540 | 1,440 | |||
| Deferred Taxes & Provisions | ||||||||||||||
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | ||||||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | ||||||||||||||
| Other Short Term Loans | ||||||||||||||
| Long term loans | ||||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||
| other long term liabilities | ||||||||||||||
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | 154,973 | |||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 90,673 | 25,302 | 102,538 | -18,907 | 28,006 | -31,856 | 13,932 | 20,195 | 18,779 | 9,051 | -32,285 | -11,593 | 159,009 | |
| overdraft | ||||||||||||||
| change in cash | 90,673 | 25,302 | 102,538 | -18,907 | 28,006 | -31,856 | 13,932 | 20,195 | 18,779 | 9,051 | -32,285 | -11,593 | 159,009 |
hughes syndrome foundation Credit Report and Business Information
Hughes Syndrome Foundation Competitor Analysis
Perform a competitor analysis for hughes syndrome foundation by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in RG21 area or any other competitors across 12 key performance metrics.
hughes syndrome foundation Ownership
HUGHES SYNDROME FOUNDATION group structure
Hughes Syndrome Foundation has no subsidiary companies.
Ultimate parent company
HUGHES SYNDROME FOUNDATION
07268671
hughes syndrome foundation directors
Hughes Syndrome Foundation currently has 7 directors. The longest serving directors include Dr David D'Cruz (Jun 2010) and Dr John Wolffe (Jun 2010).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr David D'Cruz | England | 65 years | Jun 2010 | - | Director |
| Dr John Wolffe | United Kingdom | 80 years | Jun 2010 | - | Director |
| Baroness Estelle Morris | England | 72 years | Dec 2011 | - | Director |
| Rt Hon Baroness Estelle Morris | United Kingdom | 67 years | Dec 2011 | - | Director |
| Professor Anisur Rahman | England | 60 years | Mar 2015 | - | Director |
| Mr James Turner | England | 68 years | May 2018 | - | Director |
| Mr Christopher Mansbridge | England | 38 years | Jan 2020 | - | Director |
P&L
December 2023turnover
172.3k
+88%
operating profit
105.7k
0%
gross margin
36.6%
+0.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
379.8k
+0.32%
total assets
381.2k
+0.32%
cash
372.8k
+0.32%
net assets
Total assets minus all liabilities
hughes syndrome foundation company details
company number
07268671
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
June 2010
age
15
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
J E HARRIS
auditor
-
address
the orchard white hart lane, basingstoke, hampshire, RG21 4AF
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
hughes syndrome foundation Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hughes syndrome foundation.
hughes syndrome foundation Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HUGHES SYNDROME FOUNDATION. This can take several minutes, an email will notify you when this has completed.
hughes syndrome foundation Companies House Filings - See Documents
| date | description | view/download |
|---|
